Unternehmen Aimmune Therapeutics, Inc.
Aktien
A14X6J
US00900T1079
AIMT
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Compliance Officer | 57 | 01.10.20 | |
Jim Pepin
LAW | General Counsel | - | - |
Samina Bari
PRN | Corporate Officer/Principal | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 65 450 142 | 50 930 993 ( 77,82 %) | 0 | 77,82 % |
Unternehmenskontakt
Aimmune Therapeutics, Inc.
1007 US Highway 202/206 Building JR2
08807, Bridgewater
+650 614 5220
http://www.aimmune.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-2.31% | 103 Mrd. | |
+0.56% | 95.71 Mrd. | |
+1.69% | 22.02 Mrd. | |
-17.37% | 20.9 Mrd. | |
-9.30% | 17.85 Mrd. | |
-41.01% | 16.21 Mrd. | |
-14.85% | 15.52 Mrd. | |
+3.21% | 13.86 Mrd. | |
+33.54% | 12.04 Mrd. |